Radiopharm Theranostics Ltd (RADX) Debt Ratio (2024 - 2025)
Radiopharm Theranostics (RADX) posted quarterly Debt Ratio of 0.33 for Q2 2025, down 97.58% year-over-year from 13.69 in Q2 2024, and down 97.58% quarter-over-quarter from 13.69 in Q2 2024.
Radiopharm Theranostics Ltd (RADX) Debt Ratio (2024 - 2025) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Debt Ratio for 2 consecutive years, with 0.33 the latest figure, recorded in Q2 2025.
- In Q2 2025, Debt Ratio fell 97.58% year-over-year to 0.33; the TTM figure through Jun 2025 stood at 0.33 (down 97.58% YoY), while the FY2025 annual figure was 0.0, down 14.37% from the prior year.
- Debt Ratio fell to 0.33 in Q2 2025 per RADX's latest filing, from 13.69 in the prior quarter.
- Across five years, Debt Ratio topped out at 13.69 in Q2 2024 and bottomed at 0.33 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.33 |
| Jun 30, 2024 | 13.69 |